LAUSR

57.00±10.08 years) were selected for determination of To the Editor: Although the causes and mechanisms of lung cancer (LC) are still not clear, with the advances in CD62P positivity. science and technology and the progress in research methods, it has been shown that tumor cells aggregate with platelets (PLTs) and escape being recognized by the immune system. They adhere to distant vascular endothelial cells and continue to metastasize, invade and grow through the blood circulation. Therefore, the hypercoagulable state and enhancement of PLT functions promote tumor growth, invasion, and metastasis. Therefore, the effective reduction in PLT counts and their activities can help reduce the progression and prognosis of LC. We conducted this research to explore the effect of the tumor on circulating platelets in patients with LC.